These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 15123332)
1. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332 [TBL] [Abstract][Full Text] [Related]
2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. Patel NS; Mathura VS; Bachmeier C; Beaulieu-Abdelahad D; Laporte V; Weeks O; Mullan M; Paris D J Neurochem; 2010 Jan; 112(1):66-76. PubMed ID: 19818105 [TBL] [Abstract][Full Text] [Related]
4. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482 [TBL] [Abstract][Full Text] [Related]
5. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity. Yang SP; Kwon BO; Gho YS; Chae CB J Neurochem; 2005 Apr; 93(1):118-27. PubMed ID: 15773911 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Attems J; Jellinger KA; Lintner F Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541 [TBL] [Abstract][Full Text] [Related]
8. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Gouras GK; Almeida CG; Takahashi RH Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263 [TBL] [Abstract][Full Text] [Related]
9. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137 [TBL] [Abstract][Full Text] [Related]
10. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Nicoll JA; Yamada M; Frackowiak J; Mazur-Kolecka B; Weller RO Neurobiol Aging; 2004; 25(5):589-97; discussion 603-4. PubMed ID: 15172734 [TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications. Eikelenboom P; Veerhuis R; Familian A; Hoozemans JJ; van Gool WA; Rozemuller AJ Neurodegener Dis; 2008; 5(3-4):190-3. PubMed ID: 18322387 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918 [TBL] [Abstract][Full Text] [Related]
14. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain. Thal DR; Ghebremedhin E; Haass C; Schultz C Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043 [TBL] [Abstract][Full Text] [Related]
15. Isoaspartate formation and neurodegeneration in Alzheimer's disease. Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409 [TBL] [Abstract][Full Text] [Related]
16. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491 [TBL] [Abstract][Full Text] [Related]
17. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828 [TBL] [Abstract][Full Text] [Related]
18. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. Kubo T; Nishimura S; Kumagae Y; Kaneko I J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608 [TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta aggregation. Finder VH; Glockshuber R Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215 [TBL] [Abstract][Full Text] [Related]
20. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]